Research Use Limitation BPC-157 is NOT approved by FDA or EMA for human use
As one of our largest fund partners and our largest separately-managed account (SMA) manager across WIM, we already collectively serve over $100 billion of client assets
We use advanced diagnostics to determine what the immune system is reacting to, including: Autoimmune antibody panels Mycotoxin and mold testing Lyme and co-infection panels Viral reactivation markers (EBV, CMV, HHV-6) Gut microbiome and inflammation markers Food sensitivity testing Mitochondrial and oxidative stress markers These help pinpoint the underlying drivers of immune dysregulation
We note that at the August 2025 HOP Panel meeting, the HOP panel made a recommendation to create a Level 6 Neurostimulator APC
Our approach focuses on reducing oxidative stress and improving these internal conditions so that conception can occur in the most supportive environment possible
For extra hydration, follow with a light moisturizer if needed